Shanghai Haohai Biological Technology Co., Ltd.

SEHK:6826 Stock Report

Market Cap: HK$13.7b

Shanghai Haohai Biological Technology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:6826 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Dec 23BuyHK$149,800Minjie TangIndividual5,600HK$26.75

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6826?
Owner TypeNumber of SharesOwnership Percentage
Institutions25,210,49010.9%
General Public61,186,28826.6%
Individual Insiders143,880,00462.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 72.51% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
46.4%
Jie You
106,848,000HK$6.4b-2.14%no data
3.74%
Guoliang Lou
8,611,661HK$513.4m0%no data
3.69%
Jianying Wu
8,495,717HK$506.5m0%no data
3.65%
Yongtai Hou
8,408,764HK$501.3m0%no data
1.3%
Zhong Ou Fund Management Co., Ltd
2,997,903HK$178.7m0%0.09%
1.22%
Ming Ping Huang
2,800,000HK$166.9m0%no data
1.22%
Yuanzhong Liu
2,800,000HK$166.9m0%no data
1.2%
Prudence Investment Management (Hong Kong) Limited
2,757,440HK$164.4m0%100.0%
1.09%
Hwabao WP Fund Management Co., Ltd
2,513,588HK$149.9m1.34%0.14%
1.06%
GF Fund Management Co., Ltd.
2,442,349HK$145.6m0%0.02%
1.05%
Wenbin Wang
2,407,348HK$143.5m0%no data
1%
Morgan Stanley, Investment Banking and Brokerage Investments
2,293,225HK$136.7m0%no data
1%
Weidong Tao
2,291,800HK$136.6m0%no data
0.93%
The Vanguard Group, Inc.
2,146,446HK$128.0m0%no data
0.91%
Fullgoal Fund Management Co. Ltd.
2,094,176HK$124.9m0%0.02%
0.82%
Jiaxing Tongxin Asset Management Co., Ltd.
1,890,280HK$112.7m0%no data
0.65%
Bosera Asset Management Co., Ltd.
1,493,247HK$89.0m0%0.06%
0.34%
Penghua Fund Management Co., Ltd.
780,485HK$46.5m0%0.04%
0.26%
Yiyi Chen
593,964HK$35.4m0%no data
0.21%
Renbao Gan
486,500HK$29.0m0%no data
0.2%
China Southern Asset Management Co., Ltd.
450,453HK$26.9m0%no data
0.18%
Guotai Asset Management Company Limited
424,908HK$25.3m0%0.01%
0.16%
Dimensional Fund Advisors LP
369,021HK$22.0m2.24%no data
0.13%
China Asset Management Co. Ltd.
301,908HK$18.0m0%no data
0.12%
E Fund Management Co., Ltd.
285,281HK$17.0m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 01:32
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Haohai Biological Technology Co., Ltd. is covered by 17 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jingwei QiChina Merchants Securities Co. Ltd.
Xiaofang XuCitic Securities Co., Ltd.
Eva ZhaoCitigroup Inc